Long-Acting Reversible Contraception

Obstet Gynecol. 2022 Nov 1;140(5):883-897. doi: 10.1097/AOG.0000000000004967. Epub 2022 Oct 5.

Abstract

Long-acting reversible contraceptive (LARC) methods are effective options for pregnancy prevention. Currently available products in the United States include an etonogestrel implant, a copper intrauterine device (IUD), and several levonorgestrel IUDs. With increasing prevalence and duration of use, our understanding of efficacy, risks, and benefits has evolved. In addition to a brief discussion on nomenclature and LARC use within a framework of bodily autonomy and reproductive justice, this review covers clinical challenges with placement and removal, evidence-based duration of use, and how to mitigate side effects. Although all obstetrician-gynecologists as well as primary care clinicians can safely provide LARCs, complex family planning specialists are an expert referral source for challenging cases and evidence-based care as contraceptive technology continues to develop.

Publication types

  • Review

MeSH terms

  • Contraception
  • Contraceptive Agents
  • Contraceptive Agents, Female* / therapeutic use
  • Female
  • Humans
  • Intrauterine Devices, Copper* / adverse effects
  • Levonorgestrel / adverse effects
  • Long-Acting Reversible Contraception*
  • Pregnancy
  • United States

Substances

  • Levonorgestrel
  • Contraceptive Agents
  • Contraceptive Agents, Female